Hyundai Motor Co.'s IONIQ 5 all-electric model and Tucson SUV will appear in major scenes such as dynamic stunts in Marvel film's "Spider-Man: No Way Home," coming to theaters on Dec. 15.
The South Korean carmakers signed a strategic partnership with Sony Pictures Entertainment Inc. in May of last year.
Hyundai Motor expects the series of dynamic stunts in the Spider-Man film featuring the IONIQ 5 and Tucson SUV to mesmerize the audience.
Among the various marketing programs that Hyundai Motor would be carrying out with Spider-Man is a commercial for the IONIQ 5 in collaboration with Spider-Man actor Tom Holland and director John Watts.
Hyundai also plans to host a virtual campaign via the recently launched Hyundai Mobility Adventure on metaverse platform Roblox and hold special events at Hyundai Motor Studios in Seoul and Goyang.


Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Trump Administration Sued Over Suspension of Critical Hudson River Tunnel Funding
Instagram Outage Disrupts Thousands of U.S. Users
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure
The ghost of Robodebt – Federal Court rules billions of dollars in welfare debts must be recalculated
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
The pandemic is still disrupting young people’s careers
AI is driving down the price of knowledge – universities have to rethink what they offer
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition 



